Project Grant R34DA061656
Award Date 8/1/25
Completion Date 4/30/28
Dollars Obligated $287K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Rhode Island, USA
Similar Awards
- This $677,589 Project Grant award from the National Institutes of Health (NIH) Office of the Director's Trans-NIH Research Support program (CFDA 93.310) supports the development and pilot testing of a novel HIV prevention program targeting women experiencing incarceration. The "FIT for PrEP" (F4P) program aims to link these high-risk women to post-release pre-exposure prophylaxis (PrEP) services and address associated social determinants of health during community re-entry. Key aspects...
- This federal Project Grant award for $657,907 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a 5-year longitudinal analysis to understand the impact of expanding pharmacists' scope of practice on the uptake and retention of pre-exposure prophylaxis (PrEP) for HIV prevention. The project aims to integrate multiple data sources, including policy, census, survey, and medical claims data, to...
- This $731,738 Project Grant awarded by the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) will fund a pilot feasibility study to integrate pre-exposure prophylaxis (PrEP) into emergency department and urgent care settings using a patient-centered decision support tool. The goal is to improve PrEP awareness, access, and uptake among groups at highest risk for acquiring HIV, such as men who have sex with men, young people, racial/ethnic minorities, and women of...
- This Project Grant award of $2,332,500.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to transform systems of care in Washington state prisons to better address HIV, HIV risk, and substance use disorders. The key products and services to be delivered include: Building the foundation for a "prison learning health system" to improve the quality, efficiency, and reach of HIV treatment, HIV prevention, and...
- This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $193,754 to The Children's Hospital Corporation (dba Boston Children's Hospital) to develop an implementation strategy for pre-exposure prophylaxis (PrEP) in pediatric primary care settings. The key objectives are to: 1) explore barriers and facilitators to PrEP discussions, prescribing, and persistence among adolescents and young adults...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is for $764,165 to develop and evaluate the CONNECT program. The CONNECT program aims to increase HIV and substance use care among survivors of sexual trafficking through a digital intervention delivered via street medicine. The award will fund an open trial (N=12) and a randomized pilot trial (N=60) to assess the feasibility, acceptability, and...
- This Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to develop and pilot test a community health worker-delivered PrEP decision aid to facilitate PrEP initiation among Black women seeking HIV testing services in Eastern Virginia. The $179,731 award, with a project period from September 1, 2025 to August 31, 2030, will involve in-depth qualitative interviews to inform the adaptation of a PrEP...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $753,286 to develop and pilot an integrated HIV/overdose education and naloxone distribution (OEND) peer navigation intervention targeting Latinx people who use and sell drugs (PWUSD) in Kensington, Philadelphia. The 3-year study aims to train 45 PWUSD in naloxone use and distribution, and link them to pre-exposure prophylaxis (PrEP) services through...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $743,492 to Kaiser Foundation Hospitals to conduct a longitudinal study evaluating the effects of HIV pre-exposure prophylaxis (PrEP) on cardiovascular, kidney, and metabolic health outcomes. The study will leverage electronic health record data from integrated health systems in California and the mid-Atlantic region to examine...
- This federal Project Grant award of $1,210,300 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development of novel polyvalent HIV vaccines to protect people who inject drugs (PWID) against intravenous HIV transmission. The project aims to create a vaccine that can elicit high levels of immune responses to rapidly clear multiple HIV strains that may be transmitted through needle use. The grant was awarded to Beth...